Insight Molecular Diagnostics Inc
(IMDX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,778 | -19,375 | -15,415 | -8,509 | -4,704 |
| Depreciation Amortization | 186 | 663 | 475 | 295 | 131 |
| Accounts payable and accrued liabilities | 999 | -48 | 227 | 61 | 100 |
| Other Working Capital | 682 | -686 | -642 | -446 | -310 |
| Other Operating Activity | -842 | 6,061 | 5,314 | 2,028 | 1,493 |
| Operating Cash Flow | $-2,753 | $-13,385 | $-10,041 | $-6,571 | $-3,290 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -91 | -85 | -55 | -16 |
| Net Acquisitions | N/A | 934 | 934 | 934 | 502 |
| Investing Cash Flow | $-5 | $843 | $849 | $879 | $486 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,982 | 1,982 | 1,982 | 1,982 |
| Debt Repayment | -281 | -398 | -179 | -108 | -47 |
| Common Stock Issued | 8,051 | 8,384 | 8,239 | 2,288 | 2,047 |
| Financing Cash Flow | $7,770 | $9,968 | $10,042 | $4,162 | $3,982 |
| Beginning Cash Position | 7,600 | 10,174 | 10,174 | 10,174 | 10,174 |
| End Cash Position | 12,612 | 7,600 | 11,024 | 8,644 | 11,352 |
| Net Cash Flow | $5,012 | $-2,574 | $850 | $-1,530 | $1,178 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,753 | -13,385 | -10,041 | -6,571 | -3,290 |
| Capital Expenditure | -5 | -91 | -85 | -55 | -16 |
| Free Cash Flow | -2,758 | -13,476 | -10,126 | -6,626 | -3,306 |